tiprankstipranks
Response Genetics (RGDXQ)
OTHER OTC:RGDXQ
US Market
Holding RGDXQ?
Track your performance easily

Response Genetics (RGDXQ) Stock Price & Analysis

9 Followers

RGDXQ Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

15.47%84.53%
Insiders
Mutual Funds
15.47% Other Institutional Investors
84.53% Public Companies and
Individual Investors

RGDXQ FAQ

What was Response Genetics’s price range in the past 12 months?
Currently, no data Available
What is Response Genetics’s market cap?
Currently, no data Available
When is Response Genetics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Response Genetics’s earnings last quarter?
Currently, no data Available
Is Response Genetics overvalued?
According to Wall Street analysts Response Genetics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Response Genetics pay dividends?
    Response Genetics does not currently pay dividends.
    What is Response Genetics’s EPS estimate?
    Response Genetics’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Response Genetics have?
    Response Genetics has 38,795,000 shares outstanding.
      What happened to Response Genetics’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Response Genetics?
      Currently, no hedge funds are holding shares in RGDXQ
      ---

      Response Genetics Stock Smart Score

      10
      Unlock Smart Score
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Company Description

      Response Genetics

      Response Genetics, Inc. is engaged in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies. The company was founded by David A. Smith and Kathleen Danenberg on September 23, 1999 and is headquartered in Los Angeles, CA.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Genetic Technologies
      Fulgent Genetics
      Myriad Genetics
      Kura Oncology
      Popular Stocks
      ---
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis